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Abstract The e⁄ect of pretreatment with pertussis toxin
at the doses of 0.25 and 0.50 µg per mouse ICV on the
amnesic e⁄ect produced by baclofen (0.14 mg kg1
IP), diphenhydramine (1530 mg kg1 IP) and scopo-
lamine (0.55 mg kg1 IP) was investigated in the
mouse passive avoidance test. Ten days after a single
injection of pertussis toxin, baclofen (24 mg kg1 IP)
amnesia was prevented. By contrast, pertussis toxin had
no e⁄ect on diphenhydramine- and scopolamine-
induced amnesia. Pretreatment with pertussis toxin at
both doses used did not impair motor coordination of
the mice, as revealed by the rota-rod test. The present
results indicate that the activation of pertussis toxin-
sensitive G-proteins represents an important transduc-
tion step in memory impairment induced by GABAB
(γ-aminobutyric acid B) agonists, but not by antihist-
aminic and antimuscarinic drugs.
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Introduction
The role of neurotransmitters in learning and memory
has been intensively investigated in recent years. It has
become evident that modulation of several neuro-
transmitter systems, including the GABAergic, inßu-
ences memory consolidation processes for various
learning tasks and in di⁄erent animal species.
GABA is the main inhibitory neurotransmitter in
the brain. It acts on two di⁄erent types of target recep-
tors: GABAA and GABAB. GABAA receptors are cou-
pled with benzodiazepine receptors and Cl[ channels,
while GABAB receptors are coupled with G-proteins
(Hill et al. 1984). GABAA and GABAB receptors have
somewhat di⁄erent physiological actions. However,
they play an important role in learning and memory.
Systemic picrotoxin (GABAA antagonist) administra-
tion has long been known to enhance memory facili-
tation (Breen and McGaugh 1961), whereas the
activation of GABAA receptors impairs memory per-
formances (Jerusalinsky et al. 1994). Similarly, the
GABAB agonist baclofen disrupts memory after sys-
temic, intra-amygdala or intraseptal administration
(Swartzwelder et al. 1987; Castellano et al. 1989;
Stackman and Walsh 1994). Cognitive processes,
including learning and memory, can be ameliorated by
GABAB receptor antagonists (Carletti et al. 1993;
Mondadori et al. 1993).
The antihistaminics are known to exert a variety of
e⁄ects on the central nervous system. The Þrst gener-
ation of H1 antagonists can both stimulate and depress
the central nervous system. Stimulation occasionally is
encountered in patients given therapeutic doses, but it
is a striking feature of poisoning, which can result in
convulsions, particularly in infants (Faingold and Berry
1972). Central depression, on the other hand, usually
accompanies therapeutic doses of the H1 antagonists,
and appears to be related to occupancy of cerebral H1
receptors (Simons and Simons 1994). Diminished alert-
ness, slowed reaction times, somnolence or impairment
of cognitive functions are common manifestations
(Simons and Simons 1994). The ethanolamines, such
as diphenhydramine, are particularly prone to cause
sedation (Carruthers et al. 1978). Moreover, the admin-
istration of diphenhydramine further reduces learning
ability in patients with seasonal allergic rhinitis in
whom learning performances are already impaired by
allergy symptoms (Vuurman et al. 1996). 
The Þrst aim of the present study was to investigate
the potential amnesic e⁄ect of diphenhydramine in the
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mouse passive avoidance test. The GABAB and hista-
minergic receptors have been demonstrated to interact
with metabotropic receptors coupled to G-proteins
(Birnbaumer 1990) leading to the modulation of
intracellular e⁄ectors, including adenylate cyclase,
phospholipase C and ion channels (Simon et al. 1991).
Since it has been demonstrated that several actions of
GABAB and histaminergic receptors can be mediated
by pertussis toxin-sensitive G-proteins (Bowery 1993;
Arrang 1994; Galeotti et al. 1996), we also thought it
worthwhile to investigate the role of Gi/o proteins in




Male Swiss albino mice (2330 g) were used. Mice were housed 15
per cage. The cages were placed in the experimental room 24 h
before the test for acclimatization. The animals were fed a standard
laboratory diet and tap water ad libitum. Mice were randomly
assigned to a saline, vehicle (water solution containing 0.01 M
sodium phosphate bu⁄er, pH = 7.0, with 0.05 M sodium chloride)
or pertussis toxin group (0.25 and 0.50 µg per mouse). Naive ani-
mals did not receive any pretreatment, whereas saline, vehicle and
pertussis toxin groups received a single intracerebroventricular
(ICV) injection on day 0. Pertussis toxin produced, 10 days after
administration, 18% and 55% deaths at the doses respectively of
0.25 and 0.50 µg per mouse. All experiments were carried out
according to the Principles of laboratory animal care.
Passive-avoidance test
The test was performed according to the step-through method
described by Jarvik and Kopp (1967), modiÞed by us. The appa-
ratus is comprised of a two-compartment acrylic box with a lighted
compartment connected to a darkened one by a guillotine door. In
the original method, mice received a punishing electrical shock as
soon as they entered the dark compartment, while in our modiÞed
method, mice, after their entry into the dark compartment, receive
a non-painful punishment consisting of a fall into a cold water bath
(10°C). For this purpose, the dark chamber was constructed with
a pitfall ßoor. The latency times for entering the dark compartment
were measured in the training test and after 24 h in the retention
test. Following a single pretreatment with vehicle or pertussis toxin,
the e⁄ect of baclofen, diphenhydramine and scopolamine was tested
10 days later. Baclofen, diphenhydramine and scopolamine were
injected intraperitoneally (IP) immediately after termination of the
training session. The maximum entry latency allowed in the reten-
tion session was 180 s. The memory degree of received punishment
was expressed as latencies recorded in the retention and training
sessions.
Rota-rod test
The apparatus consists of a base platform and a rotating rod of
3 cm diameter with a non-slippery surface. The rod was placed at
height of 15 cm from the base. The rod, 30 cm in length, was divided
into Þve equal sections by six disks. Thus up to Þve mice were tested
simultaneously on the apparatus, with a rod-rotating speed of
16 rpm. The integrity of motor coordination was assessed on the
basis of the number of falls from the rod in 30 s according to Vaught
et al. (1985). The performance time was measured before and 15,
30 and 45 min after subcutaneous administration of saline. The test
was performed 11 days after pretreatment with saline, vehicle or
pertussis toxin. Naive animals were used as unpretreated controls.
Drugs
The following drugs were used: (±) baclofen (b-p-chlorophenyl
GABA), scopolamine hydrobromide (Sigma), diphenhydramine
hydrochloride (De Angeli) and pertussis toxin (RBI).
All drugs were dissolved in isotonic (NaCl 0.9%) saline solution
immediately before use, except for pertussis toxin, which was dis-
solved in a water solution containing 0.01 M sodium phosphate
bu⁄er, pH = 7.0, with 0.05 M sodium chloride. Drug concentra-
tions were prepared in such a way that the necessary dose could be
administered in a volume of 10 ml kg[1 by IP injection or 5 µl per
mouse by ICV injection.
ICV administration was performed under ether anesthesia
according to the method described by Haley and McCormick (1957).
During anesthesia, mice were grasped Þrmly by the loose skin behind
the head. A hypodermic needle (0.4 mm external diameter) attached
to a 10 µl syringe was inserted perpendicularly through the skull
and no more than 2 mm into the brain of the mouse, where 5 µl
were then administered. The injection site was 1 mm to the right or
left from the midpoint on a line drawn through to the anterior base
of the ears. Injections were performed randomly into the right or
left ventricle. To ascertain that the drugs were administered exactly
into the cerebral ventricle, some mice were injected with 5 µl of
diluted 1 :10 India ink and their brains were examined macroscop-
ically after sectioning.
Statistical analysis
Results are given as the mean ± SEM; an analysis of variance
(ANOVA) was used to verify signiÞcance between two means. P
values < 0.05 were considered signiÞcant. Data were analyzed with
the StatView computer program for the Macintosh (1992).
Results
A comparison between saline- and vehicle-treated mice
in the mouse passive avoidance test is reported in Fig. 1.
No di⁄erence between the entrance latency of reten-
tion and training sessions was observed between the
two groups.
Amnesic e⁄ect of baclofen, diphenhydramine
and scopolamine
The dose-response curves for baclofen (0.14 mg kg[1
IP), diphenhydramine (1530 mg kg[1 IP) and scopo-
lamine (0.55 mg kg[1 IP) in the mouse passive avoid-
ance test are reported respectively in Figs. 2, 3 and 4.
All compounds, injected immediately after the training
session, were endowed with amnesic properties. This
e⁄ect was dose-dependent and the statistical signi-
Þcance was reached, starting from the dose of
2 mg kg[1 IP for baclofen (Fig. 2), 20 mg kg[1 IP for
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diphenhydramine (Fig. 3) and 1 mg kg[1 IP for scopo-
lamine (Fig. 4). The maximum amnesic e⁄ect was
obtained at 4 mg kg[1 IP for baclofen (Fig. 2),
30 mg kg[1 IP for diphenhydramine (Fig. 3) and
5 mg kg[1 IP for scopolamine (Fig. 4) and therefore
higher doses were not investigated.
E⁄ect of pertussis toxin on amnesia
The amnesia induced by baclofen (24 mg kg[1 IP)
was prevented, in the mouse passive avoidance test, by
pretreatment with pertussis toxin (0.25 µg per mouse
ICV) injected 10 days before the training session (Fig.
5). Pertussis toxin pretreatment enhanced the entrance
latency in the retention session up to a value compa-
rable to that produced by control animals in both
groups of mice treated with baclofen (Fig. 5). By con-
trast, the administration of pertussis toxin (0.250.5 µg
per mouse ICV) was not able to prevent diphenhy-
dramine (20 mg kg1 IP, Fig. 6; 30 mg kg[1 IP, data
not shown) and scopolamine (1 mg kg[1 IP, data not
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Fig. 1 Comparison between saline (h)- and vehicle (  )-treated
mice in the mouse passive avoidance test. Saline and vehicle were
injected ICV 10 days before performing the test. All animals were
injected with saline IP immediately after the training session.
Vertical lines give SEM; the number of mice was between 32 and
57. *P < 0.001 in comparison with corresponding training session
values
Fig. 2 Dose-response curve of baclofen in the mouse passive
avoidance test. Baclofen (  ) (0.14.0 mg kg1) and saline (h) were
injected IP immediately after the training session; vertical lines give
SEM; in each column is the dose of baclofen administered.
*P < 0.05, **P < 0.01 in comparison with saline-treated mice
Fig. 3 E⁄ect of diphenhydramine in the mouse passive avoidance
test. Diphenhydramine (1530 mg kg[1) (    ) and saline (h) were
injected IP immediately after the training session; vertical lines give
SEM; in each column is the dose of diphenhydramine administered.
The number of mice was between 19 and 32, with the exception of
the saline group (n = 57). *P < 0.01 in comparison with saline-
treated mice
Fig. 4 Dose-response curve of scopolamine in the mouse-passive
avoidance test. Scopolamine (0.15.0 mg kg[1) (    ) and saline (h)
were administered IP immediately after the training session; verti-
cal lines give SEM; in each column is the dose of scopolamine admin-
istered. The number of mice was between 24 and 48. *P < 0.01,
**P < 0.001 in comparison with saline-treated mice
shown; 3 mg kg[1 IP, Fig. 7) amnesia. Pertussis toxin
(0.250.50 µg per mouse ICV), when given alone, did
not enhance the entrance latency in unamnesic mice
on the mouse passive avoidance test in comparison with
vehicle-treated mice (Figs. 5, 6, 7).
No di⁄erence in the entrance latencies of every group
in the training session of the passive avoidance test was
observed.
E⁄ect of pertussis toxin on mouse rota-rod test
The motor coordination of mice pretreated with saline,
vehicle or pertussis toxin (0.25 and 0.50 µg per mouse
ICV), and of naive mice was evaluated by using the
rota-rod test (Table 1). Rota-rod performance, tested
as number of falls in 30 s, of animals pretreated 11 days
before the test with the doses of pertussis toxin inves-
tigated, was not signiÞcantly impaired in comparison
with naive, saline- and vehicle-treated mice according
to pretest values (Table 1). Furthermore, the successive
IP injections did not elicit any behavioral side e⁄ects,
since each group progressively reduced the number of
falls (Table 1). No di⁄erence was observed among
vehicle, saline and naive groups (Table 1).
Both of the doses of pertussis toxin tested (0.25 and
0.50 µg per mouse ICV) caused a weight loss 2 days
after injection, after which body weight slowly
increased. The body weight of naive and vehicle-treated
mice progressively increased (data not shown). The
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Fig. 5 E⁄ect of pertussis toxin (PTX) pretreatment on baclofen-
induced amnesia in the mouse passive avoidance test. The test was
performed 10 days after a single ICV injection of vehicle or per-
tussis toxin (0.25 µg per mouse). Baclofen (24 mg kg[1) and saline
were injected IP immediately after the training session. Vertical lines
represent SEM; the number of mice was between 20 and 40 with
the exception of saline group (n = 73). *P < 0.01, **P < 0.001 in
comparison with vehicle-saline treated mice; °P < 0.01 in compar-
ison with baclofen-treated mice
Fig. 6 E⁄ect of pertussis toxin (PTX) pretreatment on diphenhy-
dramine-induced amnesia in the mouse passive avoidance test. The
test was performed 10 days after a single ICV injection of vehicle
or pertussis toxin (0.25 and 0.50 µg per mouse). Diphenhydramine
(20 mg kg[1) and saline were injected IP immediately after the train-
ing session. Vertical lines represent SEM; the number of mice was
between 19 and 33. *P < 0.05, **P < 0.01 in comparison with vehi-
cle-saline treated mice
Fig. 7 E⁄ect of pertussis toxin (PTX) pretreatment on scopo-
lamine-induced amnesia in the mouse passive avoidance test. The
test was performed 10 days after a single ICV injection of vehicle
or pertussis toxin (0.25 and 0.50 µg per mouse). Scopolamine
(3 mg kg[1) and saline were injected IP immediately after the train-
ing session. Vertical lines represent SEM; the number of mice was
between 15 and 27. *P < 0.05, **P < 0.01 in comparison with vehi-
cle-saline treated mice
Table 1 E⁄ect of pertussis toxin (PTX) in the mouse rota-rod test.
Saline, vehicle and pertussis toxin (0.250.50 µg per mouse) were
injected ICV 11 days before the test. The number of mice was
between 14 and 20
Pretreatment Number of falls in 30 s
µg/mouse ICV
Before SC After SC saline injection
saline injection
15 min 30 min 45 min
 2.9 – 0.5 1.1 – 0.4 1.0 – 0.4 0.8 – 0.4
Saline 2.2 – 0.3 1.8 – 0.3 1.4 – 0.2 0.8 – 0.2
Vehicle 2.9 – 0.5 1.6 – 0.5 0.8 – 0.4 0.6 – 0.4
PTX 0.25 2.7 – 0.3 2.0 – 0.4 1.2 – 0.3 1.1 – 0.3
PTX 0.50 2.3 – 0.5 1.8 – 0.5 1.6 – 0.5 1.2 – 0.5
gross behavior of pertussis toxin-treated mice was com-
parable to that of the vehicle-treated group.
Discussion
The present study provides evidence of the involvement
of pertussis toxin-sensitive G-proteins in the baclofen
amnesic e⁄ect, indicating the important role of per-
tussis toxin-sensitive G-proteins as a transduction step
following the activation of GABAB receptors. Injection
of mice with pertussis toxin inhibits the amnesia
induced by the GABAB receptor agonist baclofen. The
stimulation of GABAB receptors provokes an inhibi-
tion of adenylate cyclase, the opening of several K+
channels in central neurons and the reduction of Ca2+
currents in cultured sensory neurons by a pertussis
toxin-sensitive mechanism (Bowery 1993). Unilateral
injection of pertussis toxin in the rat hippocampus
resulted in a reduction of baclofen-stimulated GTPase
activity and in a reduction of GABAB receptor bind-
ing sites in the rat brain (Knott et al. 1993). It was not
unexpected, therefore, that pertussis toxin prevents
baclofen amnesia.
Pertussis toxin inactivates several G-proteins (Gi/o
proteins) by ADP-ribosylation of a speciÞc C-terminal
cystein (Hepler and Gilman 1992). The degree of ADP-
ribosylation of Gi/o proteins was not evaluated by bio-
chemical techniques. However, previous studies in mice
reported that baclofen-induced analgesia, obtained at
the same doses at which it exerts amnesic e⁄ect, was
prevented by pertussis toxin pretreatment 11 days
before performing the hot-plate test (Galeotti et al.
1996), ensuring that a suƒcient level of inactivation of
Gi/o proteins was reached. Pertussis toxin penetrates
brain tissue slowly and incompletely. When the toxin
is administered into the cerebral ventricles its distrib-
ution is limited to a narrow zone close to the ventri-
cles (Van der Ploeg et al. 1991). This restricted
distribution of pertussis toxin suggests that the e⁄ects
observed in behavioral studies after ICV injection are
attributable only to a central action. 
The post-training ICV administration of histamine
has been reported to cause memory facilitation in rats
which is antagonized by the simultaneous treatment
with both promethazine and cimetidine (de Almeida
and Izquierdo 1986, 1988). In conÞrmation of the
hypothesis of a role of histamine receptors in the mod-
ulation of memory processes, we observed that the his-
tamine H1 receptor antagonist diphenhydramine causes
amnesia in the mouse passive avoidance test. The
administration of histamine H1 receptor antagonists
produces various inhibitory e⁄ects including analgesia,
which is prevented by pertussis toxin administration
(Galeotti et al. 1996). Histamine exerts its numerous
actions through interaction with three pharmacologi-
cally distinct receptor subtypes, H1, H2 and H3, which
all belong to the superfamily of G-protein coupled
receptors (Hill 1990; Arrang 1994). However, taking
into account that histamine can modulate the release
of several neurotransmitters (Hill 1990), molecules
di⁄erent from histamine, activating Gi/o proteins as a
signal transduction mechanism, downstream from the
initial receptor interaction could be responsible for 
the diphenhydramine-induced antinociception. On the
bases of these data, the involvement of pertussis toxin-
sensitive G-proteins in the diphenhydramine amnesic
e⁄ect was investigated. However, diphenhydramine-
induced amnesia does not appear to be related to the
activation of a Gi/o protein, since it is not prevented
by pretreating mice with pertussis toxin. Many of the
Þrst generation H1 antagonists tend to inhibit responses
to acetylcholine that are mediated by muscarinic recep-
tors and this anticholinergic property has been pro-
posed as responsible for some of the central actions of
the antihistaminics. The mechanism of antimotion sick-
ness e⁄ect (Jaju and Wang 1971) and the induction of
a sleeplike electroencephalographic activity (White and
Boyajy 1960) of diphenhydramine, as well as the abil-
ity of several antihistaminics to antagonize isolation-
induced Þghting in mice (Barnett et al. 1971), have been
suggested to be due to their anticholinergic activity.
These atropine-like actions are suƒciently prominent
in some of the drugs to appear during clinical use. That
anticholinergic drugs exert amnesic e⁄ects has long
been observed. The administration of scopolamine, a
muscarinic ACh receptor antagonist, results in
impaired learning and memory in humans (Frumier
et al. 1976) and animals (Dilts and Berry 1967; Levin
and Bowman 1986). Some muscarinic receptor sub-
types have been reported to be coupled to pertussis
toxin-sensitive G-proteins (the M2 and m4 subtypes)
modulating adenylate cyclase and several ion channels,
whereas others, such as M1, M3 and m5, are linked to
G-proteins that activate phospholipase C (CaulÞeld
1993). The agonist regulation of phospholipase C
appears to involve at least two separate mechanisms:
the activation of a pertussis toxin-sensitive G-protein
or, more commonly, the activation of pertussis toxin-
insensitive G-proteins (Park et al. 1993). The mus-
carinic receptor subtype mainly involved in the
modulation of memory processes is the M1 subtype
which, when expressed in Chinese hamster oocytes
(CHO), selectively activates pertussis toxin-insensitive
G-proteins (Gq and G11) (Mullaney et al. 1993), that
in turn activate phospholipase C (CauÞeld 1993).
Furthermore, the activation of the central postsynap-
tic M1 receptors produces antinociception (Bartolini
et al. 1992) through a molecular mechanism that does
not involve Gi/o proteins (Galeotti et al. 1996). In our
experimental conditions, the amnesia induced by
scopolamine is not a⁄ected by pretreatment with per-
tussis toxin, indicating the lack of involvement of Gi/o
proteins in the inhibition of cognitive performances
produced by the blockade of the muscarinic receptors.
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The pharmacological proÞle similarity between diphen-
hydramine and scopolamine suggests that the amnesia
induced by the H1 antagonist may be related to its
antimuscarinic properties.
Studies in the rat (Claro et al. 1986) and mouse
(Kendall and Hill 1988) cerebral cortex, and guinea-
pig brain slices (Daum et al. 1984), have shown that
histamine activates inositol phospholipid hydrolysis
which appeared to be mediated by the activation of the
H1 receptor subtype and selectively inhibited by H1
receptor antagonists. The activation of inositol phos-
pholipid hydrolysis enhanced the levels of several sec-
ond messengers and protein kinase C, involved in the
modulation of memory processes (Tanaka et al. 1993).
The same intracellular events can also be obtained after
activation of the cholinergic system (CauÞeld 1993).
Therefore, we cannot exclude that diphenhydramine, in
inducing its amnesis e⁄ect, could be working at hista-
minergic and/or muscarinic receptors. 
Pertussis toxin prevents the activation, by receptor
stimulation, of Gi/o proteins which are involved in the
actions of several inhibitory neurotransmitters. For this
reason, ICV injection of the toxin has been reported to
produce widespread side e⁄ects, which can make inter-
pretation of results from behavioral studies diƒcult. In
our conditions, mice treated with doses of pertussis
toxin of 0.50 and 0.25 µg per mouse ICV lost weight,
but the motor coordination of mice pretreated with both
pertussis toxin doses was not impaired, making the
results obtained in the passive avoidance test reliable.
In conclusion, the present data demonstrate that per-
tussis toxin-sensitive G-proteins represent an essential
step in the transduction mechanism underlying the
amnesia induced by activation of the GABAergic sys-
tem. On the other hand, the inhibition of memory
processes produced by a block of the histaminergic and
cholinergic systems did not appear to be related to the
activation of Gi/o proteins.
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